Target intelligence / Profile preview

Nitrate ion (NO3-)

Target
NO3-
Molecular classification
Inorganic anion, Nitrogen oxide, Metabolite, Nutrient
01

Overview

Nitrate (NO3-) is an inorganic anion that serves as a vital component of the human nitrate-nitrite-nitric oxide (NO) pathway. While historically considered a stable and inert end-product of NO metabolism, nitrate is now recognized as a critical reservoir for the endogenous production of nitric oxide, particularly under conditions of hypoxia or acidosis where the oxygen-dependent L-arginine-NOS pathway is compromised. In humans, dietary nitrate from sources like green leafy vegetables is concentrated in the saliva, reduced to nitrite by oral commensal bacteria, and subsequently converted into bioactive nitric oxide in various tissues, where it promotes vasodilation and improves mitochondrial efficiency. Clinically, organic nitrates such as nitroglycerin and isosorbide mononitrate have been used for over a century as potent vasodilators for treating angina pectoris and heart failure. However, their therapeutic utility is often limited by the development of nitrate tolerance and significant safety risks, including severe hypotension when administered alongside phosphodiesterase-5 (PDE5) inhibitors.

Other names
Nitrate ionNO3-Nitrate(V)Nitrate anionAzotateInorganic nitrate
02

Mechanism of action

Nitrate is reduced to nitrite and subsequently to nitric oxide (NO) by enzymes such as xanthine oxidoreductase; NO then activates soluble guanylate cyclase (sGC) to increase intracellular cGMP, leading to smooth muscle relaxation and vasodilation.

03

Biological functions

Vascular tone regulationNitrogen source for protein synthesis (in plants/bacteria)Precursor to nitric oxide (NO)Mitochondrial respiration regulationCellular signalingBlood pressure homeostasisMetabolic efficiency enhancement
04

Disease associations

HypertensionAngina pectorisCardiovascular diseaseIschemia-reperfusion injuryHeart failureMetabolic syndromeErectile dysfunction (via drug-drug interactions)
05

Safety considerations

Nitrate tolerance (tachyphylaxis)Severe hypotensionMethemoglobinemiaHeadache (vasodilation-induced)Contraindication with PDE5 inhibitorsPotential formation of carcinogenic N-nitroso compounds
06

Interacting drugs

Nitroglycerin

7 more in the full profile.

07

Biomarkers

Plasma nitrate concentrationUrinary nitrate levelsSalivary nitrate concentrationFractional exhaled nitric oxide (FeNO)

Beyond the preview

Go deeper on Nitrate ion (NO3-).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitrate ion (NO3-).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call